Jan. 28 at 2:13 PM
$CRM $CRMG
Barclays views Salesforce as one of their most favored names in 2026, despite recent investor skepticism. The company has faced headwinds from growth deceleration (largely due to tough comparisons from the 2020-2021 COVID period) and concerns that AI might compress seat demand.
However, Barclays believes these fears are either overblown or mistimed. In 2026, they expect a reacceleration in cRPO and organic revenue growth, driven by easier comparisons, expanded sales capacity, and initial revenue contributions from AI products like Agentforce. With shares currently trading at just 14x EV/FCF for calendar year 2027, Barclays sees a compelling setup for investors to reconsider the stock.
Goldman Sachs recently initiated coverage on Salesforce with a Buy rating, citing the company’s Agentforce AI vision as a potential driver of performance. Salesforce also announced the general availability of its redesigned, AI-powered Slackbot for its enterprise customers.
